|Articles|June 1, 2009

Pharmaceutical Executive

  • Pharmaceutical Executive-06-03-2009
  • Volume 0
  • Issue 0

June TOC Supplement

June Supplement TOC

Agency Confidential: The Scoop- What Your Agency Doesn't Want To Tell You

I've Seen The Revolution and It's Not Working

Agency Buzz

Elaine EisenPRESIDENT | CORBETT WORLDWIDE HEALTHCARE COMMUNICATIONS

Ahnal PurohitPRESIDENT AND CEO | PUROHIT NAVIGATION

Al TopinPRESIDENT | TOPIN and ASSOCIATES

Jon HudsonVICE PRESIDENT OF MEDIA AND DIGITAL SERVICES | MEDTHINK COMMUNICATIONS

Geoff MelickEVP/INTERACTIVE MARKETING and EINNOVATION | KINECT INTERACTIVE DIGITAL COMMUNICATIONS

Carleen KellyPRESIDENT | SURGE WORLDWIDE HEALTHCARE COMMUNICATIONS

Ross FetterolfVP OF DIGITAL STRATEGY | IGNITE HEALTHPharmaceuticals

Jeff BurkelCMO | MICROMASS COMMUNICATIONS

Joe DaleyPRESIDENT | GSW WORLDWIDE/US OPERATIONS

Didi DiscarPARTNER | MEDACCESS

Frank X. PowersEXECUTIVE VICE PRESIDENT | DUDNYK

Donna WrayMANAGEMENT ADVISOR, LEADER OF INTERNET AND RELATIONSHIP MARKETING PRACTICE | TGAS ADVISORS

Jay CarterSENIOR VICE PRESIDENT, DIRECTOR OF CLIENT SERVICES | ABELSONTAYLOR

Wendy BlackburnEXECUTIVE VICE PRESIDENT | INTOUCH SOLUTIONS

Kerry HiltonPRESIDENT AND CEO | HC and B HEALTHCARE COMMUNICATIONS

Rich CampbellSTRATEGIC PARTNER | REGAN CAMPBELL WARD MCCANN

Articles in this issue

over 16 years ago

I've Seen The Revolution and It's Not Working

almost 17 years ago

Frank X. Powers, DUDNYK

almost 17 years ago

Elaine Eisen, CORBETT WORLDWIDE HEALTHCARE COMMUNICATIONS

almost 17 years ago

Didi Discar, MEDACCESS

almost 17 years ago

Rich Campbell, REGAN CAMPBELL WARD?MCCANN

almost 17 years ago

Joe Daley, GSW WORLDWIDE

almost 17 years ago

Kerry Hilton, HC&B HEALTHCARE COMMUNICATIONS

almost 17 years ago

Jon Hudson, MEDTHINK COMMUNICATIONS

almost 17 years ago

Jeff Burkel, MICROMASS COMMUNICATIONS

almost 17 years ago

Wendy Blackburn, INTOUCH SOLUTIONS

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

Related Content